Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-15 Shook David Sale −8,638 $2.20 $19K 190,955
2025-01-03 Shook David Grant or award +59,000 199,593
2025-01-03 Shook David Grant or award · Stock Option (right to buy) +117,500 117,500
2024-08-21 Shook David Grant or award −1,352 $5.11 $7K 138,593
2024-07-15 Shook David Grant or award +23,421 139,945
2024-07-15 Shook David Grant or award · Stock Option (right to buy) +30,000 30,000
2024-06-18 Shook David Chief Medical Officer Sale −456 $5.60 $3K 116,524
2024-01-16 Shook David Chief Medical Officer Sale −3,552 $8.74 $31K 114,980
2024-01-04 Shook David Chief Medical Officer Grant or award +56,000 118,532
2024-01-04 Shook David Chief Medical Officer Grant or award · Stock Option (right to buy) +112,500 112,500
2023-08-21 Shook David Chief Medical Officer Sale −1,331 $1.83 $2K 60,532
2023-07-01 Shook David Chief Medical Officer Grant or award · Stock Option (right to buy) +208,000 208,000
2023-06-20 Shook David Chief Medical Officer Sale −439 $4.85 $2K 61,863
2023-01-17 Shook David Chief Medical Officer Sale −175 $5.49 $961 60,302
2023-01-13 Shook David Chief Medical Officer Grant or award +37,500 60,477
2023-01-13 Shook David Chief Medical Officer Grant or award · Stock Option (right to buy) +75,000 75,000

Page 1 of 1 · 16 trades